Pharvaris N.V. (NQ: PHVS )
20.06
-0.49
(-2.38%)
Streaming Delayed Price
Updated: 11:04 AM EST, Nov 15, 2024
Add to My Watchlist
Headline News about Pharvaris N.V.
FDA Clears Pharvaris' Trial For Investigational Drug For Swollen Blood Vessels, Stock Jumps
January 22, 2024
Via Benzinga
Exposures
Product Safety
Analyst Expectations for Pharvaris's Future
December 07, 2023
Via Benzinga
8 Analysts Have This to Say About Pharvaris
August 15, 2023
Via Benzinga
Analyst Expectations for Pharvaris's Future
July 17, 2023
Via Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
5 Analysts Have This to Say About Pharvaris
June 26, 2023
Via Benzinga
What 4 Analyst Ratings Have To Say About Pharvaris
April 06, 2023
Via Benzinga
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
December 06, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Higher; Private Payrolls Rise By 103,000 In November
December 06, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via Benzinga
Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
September 11, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday
August 18, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.